These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5455563)

  • 1. Biochemical effects of chloroquine therapy in porphyria cutanea tarda.
    Vogler WR; Galambos JT; Olansky S
    Am J Med; 1970 Sep; 49(3):316-21. PubMed ID: 5455563
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporation of (4-14 C) -aminolaevulinate into urinary porphyrins in porphyria cutanea tarda: effect of chloroquine therapy.
    Taljaard JJ; Shanley BC; Joubert SM; Deppe WM
    Clin Sci; 1973 Jun; 44(6):571-81. PubMed ID: 4713665
    [No Abstract]   [Full Text] [Related]  

  • 3. A neurological disorder in porphyria cutanea tarda.
    Asmal AC; Vinik AI; Joubert SM
    S Afr Med J; 1970 Jul; 44(27):781-4. PubMed ID: 4317550
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 5. Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects.
    Saltzer EI; Redeker AG; Wilson JW
    Arch Dermatol; 1968 Nov; 98(5):496-8. PubMed ID: 5693347
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute intermittent porphyria. A clinical, biochemical and family study.
    Kreimer-Birnbaum M; Mosovich LL; Bannerman RM
    J Med; 1971; 2(3):149-66. PubMed ID: 5289639
    [No Abstract]   [Full Text] [Related]  

  • 8. Porphyria cutanea tarda-a genetic disease? A biochemical and fluorescence microscopical study in four families.
    Dehlin O; Enerbäck L; Lundvall O
    Acta Med Scand; 1973 Oct; 194(4):265-70. PubMed ID: 4749164
    [No Abstract]   [Full Text] [Related]  

  • 9. The molecular basis of the action of chloroquine in porphyria cutanea tarda.
    Scholnick PL; Epstein J; Marver HS
    J Invest Dermatol; 1973 Oct; 61(4):226-32. PubMed ID: 4744026
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of porphyria cutanea tarda with chloroquine.
    Kordac V; Semrádová M
    Br J Dermatol; 1974 Jan; 90(1):95-100. PubMed ID: 4811840
    [No Abstract]   [Full Text] [Related]  

  • 11. The therapeutic effect of chloroquine. Hepatic recovery in porphyria cutanea tarda.
    Kowertz MJ
    JAMA; 1973 Jan; 223(5):515-9. PubMed ID: 4739135
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chloroquine therapy in porphyria cutanea tarda].
    Snitker G
    Ugeskr Laeger; 1971 Aug; 133(33):1605-10. PubMed ID: 5099470
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and treatment of the porphyrias.
    Goldberg A
    Proc R Soc Med; 1968 Feb; 61(2):193-6. PubMed ID: 5637835
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma porphyrin concentrations in porphyria cutanea tarda.
    Moore MR; Thompson GG; Allen BR; Hunter JA; Parker S
    Clin Sci Mol Med; 1973 Nov; 45(5):711-4. PubMed ID: 4759516
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.
    Swanbeck G; Wennersten G
    Br J Dermatol; 1977 Jul; 97(1):77-81. PubMed ID: 889703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.
    Miyagi K; Cardinal R; Bossenmaier I; Watson CJ
    J Lab Clin Med; 1971 Nov; 78(5):683-95. PubMed ID: 5128821
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda.
    Felsher BF; Redeker AG
    Medicine (Baltimore); 1966 Nov; 45(6):575-83. PubMed ID: 5925910
    [No Abstract]   [Full Text] [Related]  

  • 19. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of phlebotomy therapy in porphyria cutanea tarda. Its relation to the phlebotomy-induced reduction of iron stores.
    Lundvall O
    Acta Med Scand; 1971; 189(1-2):33-49. PubMed ID: 5121531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.